Closing Date: 27-12-08. Kotra Pharma (M) Sdn Bhd., is a wholly owned subsidiary of Kotra Industried Berhad, a company listed on the Kuala Lumpur Stock Exchange. KPM is one of Malaysia's leading pharmaceutical manufacturer.As a result of the company's expansion plans, we are looking for qualified candidates with excellent organization skill, resourceful, independent and good command
Close Date : 06 December 2008PHARMACEUTICAL FORMULATION SCIENTIST (OPHTHALMICS)Responsibilities: * Reports to the R & D Manager on matters pertaining to New Product Development (NPD) * Responsible for the development of new formulations and dosage forms for ophthalmic preparations as requisitioned. * To ensure products are developed and launched in accordance to Marketing requirement
LKP Shares has recommended a buy rating on Natco Pharma in its research report. "Although the generic launch of Copaxone used in treatment of multiple sclerosis is more than two years away during which Natco could face litigation from Teva as it is a USD 1.5 billion drug, we believe that the signing of the exclusive supply and distribution agreement with Mylan for the generic version of the drug i
Dabur India informed the market that they had bought 72.15% stake in Fem Care Pharma for Rs 203.7 crore ,which will be paid in full cash , They want to use this as the platform to enter into skin care market.They still have to buy an addtional 20 percent stake in Fem care which is [...]
Number of new cases of serious injury due to prescription drug use in the first three months of this year: 20,745
Percent increase over last year’s quarterly average: 38
Percent of these cases due to medication errors: 7.1
Most strikingly, the Institute [for Safe Medicine Practices] found that 10 different drugs this quarter could be linked to [...]
Aventis Pharma - Target of Rs 1000Karvy Stock Broking has maintained its buy rating on Aventis Pharma with a target of Rs 1000 in its October 13, 2008 research report. "Net revenues for the quarter are expected to be higher by 8 % to Rs 2.44 billion. Domestic revenues are expected to show 8 % growth for the quarter. Exports are expected to grow by 8 % to Rs 520 million for the quarter and continue
Dishman Pharma - Target of Rs 310Karvy Stock Broking has upgraded its rating on Dishman Pharmaceuticals & Chemicals to buy with a target of Rs 310 in its October 16, 2008 research report. "We expect revenues and earnings to grow at a CAGR of 31.4% and 27% from FY08 to FY10E driven primarily from the high margin CRAMS segment. We maintain our long term positive outlook on the company. Currently
Hi,Leading pharma client of TheIndiaJobs.com is looking for AREA BUSINESS MANAGER in MUMBAI. Designation Area Business Manager(First Line Mgr) Job Description -Responsible for leading, guiding, mentoring & coaching the team of Territory Business Manager for achieving & exceeding budgeted sales on consistent basis. -Responsible for building up co
Hi,Leading client of TheIndiaJobs.com from pharma industry is looking for Territory Business Manager in Mumbai. Designation Territory Business Manager Job Description -Responsible for achieving & exceeding budgeted sales, increasing prescriptions base in the territory and complying reporting systems & work plans. - Responsible for promoting comp
Hi,One of the leading pharma client of TheIndiaJobs.com is looking for PRODUCT MANAGER in MUMBAI & BANGALORE.Product Manager: Minimum experience of 3-4 years in product management; must have handled cardiac or diabetic portfolio for at least 2 years; key contributor in brand building process; open to explore newer concepts/ideas. Job Profile Product-wise budgeting, sales forecasting &am
Name: Pallavi Jena Q: hi,i have completed B.Pharma now i am pursuing MBA with specialization FINANCE and HR,now i am very much confused about my career, where should i go?plz guide me A: Marketing specialization has more scope with your qualification. Nothing to worry you can get good job in Pharma-MNC, IT, Biotech companies. Please speak to your Placement office to invite related companies for
Peripheral vascular disease - patient should sit with feet flat on floor to prevent hypereflexion of the knee
Myelominigocele - baby should like on abdomen with head to the side
Tegretol - interferes with actino of hormonal contraceptives, should use alternate type of birth control
Clozapine (Clozaril) - antipsychotic, treats schizophrenia, potential to suppress bone marrow and cause
Pharma giants like Pfizer and Merck are entering the generic drug (GD) market in 2009. The spokespersons from the Pfizer and Merck declared on Monday that they will be launching the generic drugs in January 2009 that will be used for the cardiovascular diseases. Pfizer specifically mentioned that it will start manufacturing a generic Viagra that will be its new product to treat erectile dysfunctio
Name: naga rani Q: now i'am doing my b pharma 4th year i want to know about job opportunities and which jobs i can getA: You can apply for jobs in following areasMarketing/Sales jobs in pharma companiesregulatory affairs Production/manufacturing of pharmaceuticalsclinical researchpharmacist-clinical/hospitalas a teacher/professoras a research scientist
A foundation populated by the giants of business, banking, government and military wants to “vet” websites and limit the spread of information that it says creates “conspiracy theories”.
The World Wide Web Consortium (W3C) says it is worried about the way the web has been “used to spread disinformation”. They want to introduce a new system that would give websites a label for trustwort
Indian Pharmaceuticals sector posted disappointment performance in the first quarter FY08-09. Fall in rupee, rise in raw material prices, increase interest rates and rise in the crude oil prices are some of key factors for the poor show. Most of the companies booked forex exchange losses and mark to market losses due to rupee depreciation. Apart form this, slow down of ANDAs filings by Indian phar
bhollar/flickr (CC)
An Update on Gardasil: Marketing Trumps Science…Billions Spent; Risks Remain Unknown (Health Beat)
Gardasil is back in the news due to reports of a higher allergic reaction rate compared to other vaccinations. But this and other reports of potentially severe side effcts begs the question: Is Gardasil really necessary? After all, writes Maggie Mahar, the [...]
Japan's Shionogi & Co. has planned to acquire Sciele Pharma Inc. of the United States at a cost of $1.42 billion, the latest foray by a Japanese drug manufacturer into overseas territory.
Japanese drug manufacturers are expanding overseas at a time when a shrinking population is darkening their domestic sales prospects. Undoubtedly, establishing additional overseas sales infrastructure has
For the past several weeks, we’ve been updating our 2008 Corporate Presentation. It’s finally complete and we’re excited to share it with you. Feel free to download a copy of the Presentation by clicking on the image above or by clicking here.
(Adobe Acrobat Reader is required to view this document. If you do not have Adobe Acrobat [...]
For the past several weeks, we’ve been updating our 2008 Corporate Presentation. It’s finally complete and we’re excited to share it with you. Feel free to download a copy of the Presentation by clicking on the image above or by clicking here.
(Adobe Acrobat Reader is required to view this document. If you do not have Adobe Acrobat [...]
Stock : Aurobindo Pharma Ltd CMP : 278 Target : 310 and 325 Potentail Upside : 10-15% This Stock is currently at oversold zone. Yesterday this stock recovered from the low of 272 with heavy volumes. Expecting a potential runup in this counter for 10-15% i short term. Call also given to our smsgupshup members marketbits. Market Bits is a free sms service run by Marketc
Scrip : - Marksans Pharma.BSE Code: - 52440452 Week H/L:- 35.16 / 4.51CMP: - 20.00Target : - 30 Medium term.Market Cap: - 718.80 Cr.Summary.Markets have crashed considerably and so has this scrip. This stock had split in Feb 08 in 1:10 ratio. History - TASC Industries (India) Ltd. was incorporated on 16th April 1992 as a Public Limited Company under the Companies Act 1956 at Bombay in the state of
Scientists from the Salk Institute’s Gene Expression Laboratory may have discovered Big Pharma’s Holy Grail of Pharmaceuticals.
A pill that would allow you to reap all of the benefits of vigorous exercise while sitting on the couch watching re-runs of Seinfeld.
How about that!
Scientists from the Salk Institute’s Gene Expression Laboratory have reported (in the July 31 advance edition of
Job Vacancies :Graduate Trainee - Recruitment Consultant - Healthcare /Pharma / LifescienceAs a part of dynamic and professional team, you will play an important role consultation and management of both clients and candidates. You will be trained with a comprehensive set of skills to enhance and develop your career as an Graduate TraineeYour Responsibilities include: * New Business development
Job Vacancies :Graduate Trainee - Recruitment Consultant - Healthcare /Pharma / LifescienceAs a part of dynamic and professional team, you will play an important role consultation and management of both clients and candidates. You will be trained with a comprehensive set of skills to enhance and develop your career as an Graduate TraineeYour Responsibilities include: * New Business development
A leading Pharmaceuticals and medical supplies distributor in Saudi Arabia is seeking:
SALES REPRESENTATIVE
- (Based in Abha, Saudi Arabia )
Medical background, minimum 3 years experience in dealing with pharmacies, clinics and hospitals.
MEDICAL REPRESENTATIVES
(Jeddah, Riyadh & Khobar)
Pharmacist with 3 years experience with hospitals and clinics.
COUNTER SALESMAN
(Riyadh)
Minimum 3
Closing Date: 8 august 2008Nam Pharma Animal Health Sdn BhdA well-established company engaged in manufacturing and distributing veterinary pharmaceutical products. We share a vision that drives our growth and success. We have the mindset of striving for better quality, processes and product development for our customers in order to achieve our goals. In view of the expansion of our business, we in
The drug Gardasil--a vaccine from Merck & Co. Inc. manufactured to inoculate women against HPV and cervical cancer--is possibly killing women instead.According to the U.S. Center for Disease Control (CDC) website, the CDC's Vaccine Adverse Event Reporting System (VAERS) "is a national program of CDC and the Food and Drug Administration (FDA) that monitors the safety of vaccines after they are
Even though medical marijuana is still illegal in most places, pharmaceutical companies are busily applying for -- and in many case, have already received -- multiple patents for medical marijuana drugs.
These include patents for synthetic derivatives (such as the oral THC pill Marinol), cannabinoid agonists (synthetic agents that bind to the brain's endocannabinoid receptors, such as HU-210) and
Plethico Pharma operates in the fast-growing herbals & nutraceuticals segments.The stock is an attractive investment pick in a bearish market
Beta: 0.2
Institutional Holding: 6.2%
Dividend Yield: 0.6% P/E: 9
M-Cap: Rs 1,309 cr
CMP: Rs 384.3
EVEN WHILE the Sensex has been falling, there are promising stocks which offer both growth and value to investors and provide a hedge against the curren
Plethico Pharma operates in the fast-growing herbals & nutraceuticals segments.The stock is an attractive investment pick in a bearish market
Beta: 0.2
Institutional Holding: 6.2%
Dividend Yield: 0.6% P/E: 9
M-Cap: Rs 1,309 cr
CMP: Rs 384.3
EVEN WHILE the Sensex has been falling, there are promising stocks which offer both growth and value to investors and provide a hedge against the curren
Qualification: B.SC.Pharma, MBA
Experience: 2 - 5 years
Location: Mumbai
Job Description -
Making / Helping in making presentation by ensuring required data
been extracted
Assisting in conducting orientation program for the marketing and
sales team on better usage of MIS
Assisting in carry out primary market research to address critical
Marketing issues
Timely and comprehensive response to
SGH
Pharmacist
visit : www.sgh.com.sg/careers
And other jobs:
Pfizer
Regulatory Affairs Executive
fax : 03 5568 6610
Genzyme
Rep
email : recruitment.apac@genzyme.com
Please quote 101 Global Jobs (Healthcare) in your application to this job!
To receive job announcements in your e-mail on a daily basis, subscribe to 101globaljobs-subscribe@yahoogroups.com.
Bafna Pharma IPO Allotment Status is out and can now be checked online. To know the allotment status of Bafna Pharma IPO keep your IPO application number in your hand and visit the registrar’s website. Select Bafna Pharma IPO and click go. Now enter your application number to check the Bafna Pharma IPO Allotment Status [...]
Bafna Pharma IPO allotment Status is ready and can be checked here :
addthis_url = 'http%3A%2F%2Fwww.rupya.com%2Farchives%2F2008%2F06%2F23%2Fbafna-pharma-ipo-allotment-status%2F';
addthis_title = 'Bafna+Pharma+IPO+allotment+Status';
addthis_pub = '';
Fundamentally a very sound company, the financial performance has been, as expected, very good.
Net sales of the company rose 8.25% at Rs.2435.90 crores. Operating expenses grew consistently: EBITDA was up 24% at Rs.435.36 crore. PBT was up 41% at Rs.291.75 crore. And despite an over 12 times rise in taxation outgo, the company posted a PAT of Rs.238.48 crore; a 19% rise over previous year.
The
Name: ajitQ: is b-pharm with mba in marketing is agood option ?what are the jobs that can be applied on this qualification ?what is the pay scale for product management team career or as a प्रोडक्टmanager in a pharma industry ?
Experience: 2 - 3 Years
Location: Delhi/NCR
Compensation: Rupees 2,25,000 - 2,75,000
Candidates must be based in Delhi NCR & have good HR Experience in Pharma industry.
Education: UG - B.B.A - Management
PG - MBA/PGDM - HR/Industrial Relations
Industry Type: Pharma/ Biotech/Clinical Research
Functional Area: HR / Administration, IR
Posted Date: 08 Jun
Job Description
To handle HR function
Sun Pharma has completed the purchase of dosage form manufacturing operations of US based Able Labs for $23.15 million (Rs 104.17 crore) through its wholly-owned subsidiary company, Sun Pharmaceutical Michigan.Now the ownership and lease rights to manufacturing operations at two sites in New Jersey, and special suites for manufacturing controlled substances, spread over an area of 275,000 sq ft. l
As we continue to celebrate our recent acquisition of ReceptoPharm, I would like to take a moment and welcome Dr. Paul Reid and Mr. Harold Rumph to the Nutra Pharma Board of Directors.
For the past several years, I have had the pleasure of working closely with both Dr. Reid and Mr. Rumph at ReceptoPharm. Their [...]
Pfizer
Rep based Klang/Kuantan/ Penang/Kuching/ KK
Regulatory Affairs Exec
fax to : 03 55686610
Summit
Rep based PJ/Butterworth
snail mail to :
Sales and Marketing Manager
Consumer Division
Summit Co (M) Sdn Bhd
Lot 6, Jln 19/1, 46300 PJ.
Zuellig
Key Account Executive/Superviso r
Rep based Klang/Mlk/Seremban
CRO
email : apply@zuelligpharma.com
Please quote 101 Global Jobs (Healthcare) in your
With dems (notably Obama) constantly declaring war on every major business that make our lives better I think it's appropriate to debunk some of dems attacks on our pharmaceutical industry:
Time to develop and market a new drug: 10-15 years
Average Cost to develop a new drug (2006): $1.318 billion
Total R&D spending on drugs in 2007: $58.8 billion
Generic share of market in 2007:...
Click
Sun Pharma, India's largest pharma company by market capitalization has failed to clinch the deal for Israeli major Taro Pharma. The merger deal, signed on May 18, 2007, stipulated a price of $7.75 per share to be paid by Sun to acquire Taro, with either of the parties having freedom to terminate the agreement after December 31, 2007. Now, Taro has rejected Sun's revised offer of $10.25 per share
Buy : Divis Laboratories CMP : Rs 1397 Target : Rs 1540 Upside : 10% Stop Loss : Rs 1365Time Frame : 5-7 Days If the investors wants some different pharma pick may be Divis Labs would be the best for short term Investor Pick. Divis Lab made a low of 1369 in past two days which is almost a double bottom which act as a great support. To be more precise can make a stop loss of 1365 and can tak
Zandu PharmaRecommendation Price - 6679.75Target Price - 8000Recommendation Date - 13-Nov-2007Recommendation Type - Long TermToday's High Price - 8220.10Target Achieved in 196 daysTarget Achieved Date - 27-May-2008Annual Gain - 43.06%Actual Gain - 23.06%www.vjondalalstreet.com/marketma.php
US HOT STOCKS: Esmark, Jazz Tech, United Natural Foods -3-
Last Update: 5/20/2008 12:06:35 PM
Among the companies seeing active trade in Tuesday’s session are Home Depot Inc.
(HD), Microsoft Corp. (MSFT), Yahoo Inc. (YHOO), Fannie Mae (FNM), and Freddie
Mac (FRE).
Home Depot Inc. (HD, $27.39, -$1.48, -5.13%), the largest U.S. home-improvement
retailer, said its first-quarter net income fell
Bafna Pharmaceuticals IPO - Bafna Pharma public issue of 64,00,000 equity shares of Rs 10 each at a price of Rs 40 per equity share (including share premium of Rs 30 per equity share) for cash aggregating Rs 25.60 crores will open for subscription on May 27, 2008 and will close on May 30, [...]
Bafna Pharmaceuticals IPO is scheduled to open for subscription on May 27, 2008. It is a fixed price IPO. IPO price has been fixed at Rs. 40 per share of face value Rs. 10 each. The public issue opens for subscription on Tuesday, May 27, 2008 and will close for subscription on May 30, 2008. [...]
>Torrent Pharmaceuticals has declared its results for the quarter ended March 2008 (Q4). The company’s revenue was down by 5% to Rs 320 crore versus Rs 337 crore.
>Century Enka has announced its results for the quarter ended March 2008 (Q4). The company registered a net loss of Rs 80 lakh versus profit of Rs 1.38 [...]
Solvay Pharma India net profit rose 65.16% to Rs 6.59 crore in the Qtr Ending Mar 2008 compared to Rs 3.99 crore in the Same Qtr YOY. Sales rose 14.07% to Rs 39.96 crore in the Qtr Ending Mar 2008 compared to Rs 35.03 crore in the Same Qtr YOY.
addthis_url [...]
Connecticut Attorney General Richard Blumenthal has asked for help against influence wielded by drugmakers in formal testimony before the state’s Legislature.
Blumenthal wants to make it illegal for drugmakers to give gifts or other benefits to physicians, citing it may influence their health care decisions despite a code of ethics the industry has already adopted.
In his view, the current code is meaningless and unenforceable. Drug companies spend more than $11 billion per year on relentless direct marketing of their drugs.
Specifically, Blumenthal proposes that Connecticut law:
Prohibit any gifts, scholarships or other items in exchange for prescribing products, a commitment to continue prescribing products or to otherwise interfere with the independence of a health care provider’s
Parallel traders are the thorn in the side for pharmaceutical companies operating in Europe. Local sales mangers see their bottom line eroded as independent exporters undercut them with their own product! The considerable efforts that pharma companies have gone to prevent this grey trade have largely failed. The majority of legal actions against traders [...]
Merck & Co. conducted its own studies on the pain pill Vioxx, then hired companies to ghostwrite reports for medical journals that appeared under the names of scientists who didn't do the majority of the research, court records show. In many cases, Merck's involvement in producing the data wasn't disclosed, according to two articles in the current Journal of the American Medical Association relying on court papers. The documents disclosed by Merck in two Vioxx lawsuits also suggest the company's control of the data allowed it to downplay the risk of death from Vioxx in patients with Alzheimer's disease, the journal's editors said in an editorial. About 250 documents show Merck employees worked alone or with publishing companies to write manuscripts and later recruited academic medical expe
Ankur Drugs & Pharma net profit rose 144.31% to Rs 19.96 crore in the Quarter Ending March 2008 compared to Rs 8.17 crore during the Prev QTR YOY 2007. Sales rose 136.80% to Rs 207.51 crore in the Quarter Ending March 2008 compared to Rs 87.63 crore during the Prev QTR YOY 2007.
addthis_url [...]
Free Intraday Tips for 15th April 08SASKEN ( Sasken Communication Technologies Ltd) ActionTrigger Price Stop LossTarget 1 Target 2BUY ABOVE138135144153S.SELL BELOW132136127118Click here for more recommendations of stocks below Rs.150 ANKURDRUGS ( Ankur Drugs And Pharma Limited) ActionTrigger Price Stop LossTarget 1 Target 2BUY ABOVE210204219229S.SELL BELOW201206195178SELAN ( Selan Exploration Technology Ltd) ActionTrigger Price Stop LossTarget 1Target 2BUY ABOVE188182198210S.SELL BELOW179183171153Read more... Did You Enjoy this Post?Subscribe Today.
Click here for more recommendations of stocks below Rs.150
Click here to Get Tips for your own Stocks
Orchid Chemicals & Pharmaceuticals Ltd has informed the market that the Company is announcing, on April 10, 2008 the formation of its wholly owned subsidiary in Japan called Orchid Pharma Japan K K (Orchid Japan). Orchid Japan, is headquartered in Tokyo, will drive Orchid’s foray into the high potential and growing Japanese generics market.
[...]
After talking to a number of shareholders, it has become apparent that many of you haven’t seen our video from Business & Beyond. This short six-minute presentation offers a great overview about us and our drug discovery and medical devices subsidiaries, ReceptoPharm and Designer Diagnostics.
In the future, we are going to be posting our videos [...]
According to The Deal’s recent interview with Dr. Matt Higgins, Management Professor at Georgia Institute of Technology, big pharma’s need to acquire new technology is increasing. He explains that expanded competition from generics and internal productivity issues with research not pumping out as many new drugs are to blame. What could potentially be viewed as [...]
Social media are shifting the way that the global economy operates. Internet journals and communities have enabled consumers to communicate their experiences with companies’ products and services to other consumers. A consequence of consumer-generated marketing is that relationship management throughout the lifecycle of a product is taking the place of mass marketing in consumer-driven industries.
Scope [...]
Faced with dwindling growth rates in the US and Europe, pharmaceutical companies are turning their attention towards emerging pharmaceutical markets whose double-digit growth is fuelled by their recent economic booms. However, although the patient potential of the emerging market countries is enormous, foreign pharma companies are currently tapping into only a fraction of the consumers, [...]
Cardiome Pharma (NASDAQ: CRME) picked a bad day for good news. According to the AP the company announced "interim midstage data showed its experimental drug...
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
Carl Icahn filed a 13D regarding his stake in Enzon Pharmaceuticals (ENZN) today.
Icahn now may be deemed to beneficially own, in the aggregate, 3,072,103 Shares, representing approximately 6.93% of Enzon's outstanding Shares (based upon the 44,322,923 Shares
Also,
"The Reporting Persons have entered into a number of derivative agreements, commonly known as Total Return Swaps, with counterparties, which agreements provide that the profit to the Reporting Persons shall be based upon the...
Continued at Todd Sullivan's ValuePlays
More than 100 year’s old, it is an integrated pharmaceutical company, recognized more popularly as...
For More Details Please Visit: www.moneybazzar.blogspot.com
This fascinating article looks at Progressive Malpractice (ignoring the fundamental economic and political roots of a crisis) and Libertarian Narcissism (promoting individual solutions for collective problems.)
Mainstream medical practitioners, the corporate media, and elected public officials ignore or cover-up the real problems with our health. Band-aid solutions are offered, but with Big Pharma spending more on lobbying than any other industry in the United States, real solutions seem unlikely to come from politicians. The result? American consumers and employers will spend over two trillion dollars this year on health insurance, pharmaceutical drugs and medical bills, while remaining among the unhealthiest people on Earth.
The author argues that even universal health care is not enough
This fascinating article looks at Progressive Malpractice (ignoring the fundamental economic and political roots of a crisis) and Libertarian Narcissism (promoting individual solutions for collective problems.)
Mainstream medical practitioners, the corporate media, and elected public officials ignore or cover-up the real problems with our health. Band-aid solutions are offered, but with Big Pharma spending more on lobbying than any other industry in the United States, real solutions seem unlikely to come from politicians. The result? American consumers and employers will spend over two trillion dollars this year on health insurance, pharmaceutical drugs and medical bills, while remaining among the unhealthiest people on Earth.
The author argues that even universal health care is not enough
About Aurobindo Pharma
One of the largest API manufacturers in Asia, Aurobindo Pharma has commercialised over hundred APIs. Aurobindo’s products are spread over six major areas encompassing Antibiotics, Anti-Retro Virals, CVS, CNS, Gastroenterologicals, and Anti-Allergics.
Aurobindo’s R & D strengths lie in developing intellectual property in non-infringing processes and resolving complex chemistry challenges. In the process, Aurobindo [...]
The service of PSD502 in the service of the treatment of untimely ejaculation.May 2007, Sciele signed an licensing concord in the service of PSD502 with Plethora Solutions.PSD502 is a proprietary formulation of two marketed drugs - lidocaine and prilocaine - dispensed by a metered administer aerosol and developed in the service of the treatment of untimely ejaculation, a disorder affecting up to 30% of men in Europe and the U.And in the service of which there currently is no FDA-approved medication treatment.Offering is applied locally when needed ( continually referred to as "on demand" therapy) and is serviceable within five minutes.Offering has been shown to dilate ejaculation latency duration whenpared with placebo in a multi-center wind up II investigation This figures was published
2007 turned out to be a great year for Nutra Pharma. We had a lot of exciting developments and now that we are finally settled into 2008, I felt it was appropriate to review some of them…
Drug Discovery
We initiated a Phase IIb/IIIa clinical trial for the treatment of Adrenomyeloneuropathy and successfully completed our 6-month patient [...]
By Shailendra BhatnagarFeb. 28 (Bloomberg) -- India's benchmark Stock Exchange moved between gains and losses today.Sun Pharmaceutical Industries Ltd., India's biggest drugmaker, gained after saying it won U.S. approval to sell its version of Roche Holdings AG's Demadex for the treatment of edema.The benchmark Sensex rose 3.46, or 0.02 percent, to 17,829.45 as of 10:05 a.m. local time in Mumbai on the last day of the expiry of monthly derivatives contracts and a day ahead of the presentation of the budget for the financial year to March 2009. The measure had advanced 2.8 percent in the past three sessions.Sun Pharmaceutical Industries Ltd. gained 9.45 rupees, or 0.8 percent, to 1,202.1. Housing Development Finance Corp., the mortgage lender partly owned by Citigroup Inc. gained for a third
It’s been a while since we last wrote on our Blog, but after several months redeveloping our Website, we are back and ready to keep the posts rolling.
For those of you who aren’t familiar with us, we are a biotech company based in Boca Raton, Florida. We’re developing treatments for neurological and autoimmune disorders, including [...]
AstraZeneca Pharma India Ltd has informed BSE that the Company has fixed January 11, 2008 as the Record Date for determining entitlement to the issue...
Click on Headline to read full Article..
orchid.pdf
addthis_url = 'http%3A%2F%2Fbirlaa.com%2F2007%2F12%2F23%2Fbuy-orchid-chemicals-and-pharma%2F';
addthis_title =...
Click on Headline to read full Article..
Pressured by drug regulators from around the world, Bayer announced today that it had agreed to withdraw its controversial heart surgery drug Trasylol after a Canadian study found that it may increase the risk of death.
The Food and Drug Administration asked the company to suspend sales of the drug, which is used to stem excessive bleeding during heart surgery, until it has been able to conduct a thorough examination of the full results of the Canadian study.Sources:New York Times November 5, 2007
Shares of Momenta Pharma (MNTA) are off 46% to $7.27, a 52-week low. The company said said Tuesday...
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
About 90 percent of the pharmaceutical industry's $21 billion marketing budget is directed at physicians, according to JAMA. There are more than 90,000 pharmaceutical representatives that visit U.S. physicians, providing free lunches, gifts, marketing paraphernalia and free medication samples. These enticements are designed to influence doctors to prescribe more drugs and more expensive drugs and have often become a substitute for objective medical evidence.
Launched in 2002, AMSA's PharmFree Campaign encourages medical schools and academic medical centers to develop policies that limit the access of pharmaceutical company representatives to their campuses and prohibit medical students and physicians from accepting gifts of any kind from these representatives. In May 2007, AMSA released its PharmFree Scorecard, which was a first-of-it's-kind ranking of medical schools according to their pharmaceutical influence policies. Of all the medical schools in the United States, five recei
Market scaled to new height of 20000 mark. Day trading recommendations gave tremendous returns like NTPC gave a return of RS 9 and Airtel gave a return of Rs 21.
Hope you all have made money with our suggestions
Buy Torrent Pharma > 164.1,165.6,169.6,172 Stop loss 161.5
Buy Glenmark > 454.1,465,479
Abbi Adest of Seeking Alpha gave us a great report on four foreign companies that are going public this week. Giant Interactive Group (GA), Scope Metals (SCPE), Akela Pharma (AKLA), and CNinsure (CISG)
Giant Interactive Group (GA) is a Chinese online game developer and operator with Total Revenue in the 6 months ending June 30, 2007 of about $90.3M and Net Income of $67.3M. They will be selling 57.2 million shares at $12.00 - $14.00 per share.
Scope Metals (SCPE)is an Israeli based distributor and supplier of finished and semi-finished m
Momenta Pharmaceuticals leverages its proprietary technology to unlock the structural secrets of complex sugars and other complex mixtures. Unique tools and approach to drug development have yielded a diversified product pipeline consisting of technology-enabled generic drugs, re-engineered drugs and novel drug candidates.Sugars play a critical role in both normal biological processes and disease Sugars, together with DNA and proteins, play a critical role in regulating biological processes and pathways throughout the human body. This makes sugars a fertile field for research and provides significant opportunity for discovering improved treatments for many diseases. To date, science has just begun to appreciate the profound role that sugars play in human biology. However, what we have learned so far is clear: The manner in which a cell produces sugars is critical for normal cell function and communicationMalfunctions in complex sugar production (and the resulting abnormalitie
